Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 13, 2026

Total Value: $472M (100.0% shares, 0.0% debt)

Holdings (14)

New Positions (1)

VTVT VTV THERAPEUTICS INC 0.4%

Value $1.883M Shares 50,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
VTVT	VTV THERAPEUTICS INC	50,000	$1.883M	0.4%	—	—	CL A NEW	918385204

Decreased Positions (1)

BBIO BRIDGEBIO PHARMA INC 72.5%

Value $342M (-9.6%) Shares 4,589,611 (-9.8%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BRIDGEBIO PHARMA INC	4,589,611 (-9.8%)	$342M (-9.6%)	72.5%	—	—	COM	10806X102

Unchanged Positions (12)

CMPS COMPASS PATHWAYS PLC 4.3%

Value $20.27M Shares 1,432,336 Est. Cost — Unrealized —

GLUE MONTE ROSA THERAPEUTICS INC 8.0%

Value $37.65M Shares 1,555,664 Est. Cost — Unrealized —

BCAX BICARA THERAPEUTICS INC 3.6%

Value $16.89M Shares 568,919 Est. Cost — Unrealized —

URGN UROGEN PHARMA LTD 0.8%

Value $3.974M Shares 108,000 Est. Cost — Unrealized —

SNDX SYNDAX PHARMACEUTICALS INC 6.1%

Value $28.79M Shares 1,316,806 Est. Cost — Unrealized —

BBOT BRIDGEBIO ONCOLOGY THERAPEUT 1.6%

Value $7.757M Shares 1,018,018 Est. Cost — Unrealized —

ACRS ACLARIS THERAPEUTICS INC 0.5%

Value $2.298M Shares 434,455 Est. Cost — Unrealized —

SRRK SCHOLAR ROCK HLDG CORP 0.9%

Value $4.237M Shares 77,031 Est. Cost — Unrealized —

EPRX EUPRAXIA PHARMACEUTICALS INC 0.5%

Value $2.148M Shares 325,000 Est. Cost — Unrealized —

BMEA BIOMEA FUSION INC 0.6%

Value $3.012M Shares 2,048,757 Est. Cost — Unrealized —

MRKR MARKER THERAPEUTICS INC 0.1%

Value $478K Shares 325,370 Est. Cost — Unrealized —

OKUR ONKURE THERAPEUTICS INC 0.1%

Value $404K Shares 88,607 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CMPS	COMPASS PATHWAYS PLC	1,432,336	$20.27M	4.3%	—	—	SPONSORED ADS	20451W101
GLUE	MONTE ROSA THERAPEUTICS INC	1,555,664	$37.65M	8.0%	—	—	COM	61225M102
BCAX	BICARA THERAPEUTICS INC	568,919	$16.89M	3.6%	—	—	COM	055477103
URGN	UROGEN PHARMA LTD	108,000	$3.974M	0.8%	—	—	COM	M96088105
SNDX	SYNDAX PHARMACEUTICALS INC	1,316,806	$28.79M	6.1%	—	—	COM	87164F105
BBOT	BRIDGEBIO ONCOLOGY THERAPEUT	1,018,018	$7.757M	1.6%	—	—	COM NEW	107924102
ACRS	ACLARIS THERAPEUTICS INC	434,455	$2.298M	0.5%	—	—	COM	00461U105
SRRK	SCHOLAR ROCK HLDG CORP	77,031	$4.237M	0.9%	—	—	COM	80706P103
EPRX	EUPRAXIA PHARMACEUTICALS INC	325,000	$2.148M	0.5%	—	—	COM	29842P105
BMEA	BIOMEA FUSION INC	2,048,757	$3.012M	0.6%	—	—	COM	09077A106
MRKR	MARKER THERAPEUTICS INC	325,370	$478K	0.1%	—	—	COM NEW	57055L206
OKUR	ONKURE THERAPEUTICS INC	88,607	$404K	0.1%	—	—	COM CL A	68277Q105